Technology
Health
Biotechnology

ProQR Therapeutics

$12.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.49%) Today
+$0.30 (2.44%) After Hours

Why Robinhood?

You can buy or sell PRQR and other stocks, options, ETFs, and crypto commission-free!

About

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. Read More The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Employees
Headquarters
Leiden, Zuid-Holland
Founded
2012
Market Cap
529.45M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
290.75K
High Today
$12.66
Low Today
$11.88
Open Price
$12.35
Volume
137.48K
52 Week High
$24.00
52 Week Low
$5.10

Collections

Technology
Health
Biotechnology
Therapy
Biopharmaceutical
Pharmaceutical
2014 IPO
Europe (Non-UK)

News

Yahoo FinanceMay 8

Here is What Hedge Funds Think About ProQR Therapeutics NV (PRQR)

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.

100
NasdaqMay 8

ProQR Announces Financial Results for the First Quarter of 2019

35
Yahoo FinanceMay 8

ProQR (PRQR) Reports Q1 Loss, Misses Revenue Estimates

ProQR (PRQR) delivered earnings and revenue surprises of -13.89% and -100.00%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

6

Earnings

-$0.49
-$0.35
-$0.22
-$0.08
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.